Ruud Albers

Ruud obtained his PhD on immunomodulation at Utrecht University and studied intestinal metabolism at Rockefeller University in New York. In 1998 he joined Unilever where he built and led the global expertise group on nutrition immunity and gut health in varying roles up to global R&D director Bioscience, Nutrition & Health Discover Platform. He initiated numerous international collaborations and is coinventor of IMPP-1. From 2007 to 2012 he chaired the ILSI-Europe taskforce on nutrition and immunity that published seminal papers on immunomodulation in humans. Since leaving Unilever in 2012, he founded Nutrileads and he acts as consultant for international ingredient, food and pharma companies.